In most patients with cirrhosis, successful percutaneous ablation or surgical resection of
hepatocellular carcinoma (HCC) is followed by recurrence. Radiofrequency ablation (RFA) …

For the treatment of small hepatocellular carcinoma (HCC), radiofrequency ablation (RFA) is
in some centers considered a first-line therapeutic option. However, such a strategy is still …

Abstract Background and Aims Percutaneous radiofrequency ablation (RFA) demonstrated
good results for the treatment of hepatocellular carcinoma (HCC) in cirrhotic patients; it is still …

Background Radiofrequency ablation (RFA) offers an alternative treatment in some
unresectable hepatocellular carcinoma (HCC) patients with disease confined to the liver. We …

Abstract Background and Aim In patients with cirrhosis and small hepatocellular carcinoma
(HCC), thermal ablation is currently recognized as an effective local treatment. Among …

Objective: Determine the histologic response-rate (complete versus partial tumor extinction)
after single radiofrequency ablation (RFA) of small hepatocellular carcinoma (HCC) arising …

If liver transplantation is not feasible, partial resection is considered the treatment of choice
for hepatocellular carcinoma (HCC) in patients with cirrhosis. However, in some centers the …

Purpose To evaluate the long-term outcomes of radiofrequency ablation (RFA) as a first-line
therapy for early-stage hepatocellular carcinoma (HCC) and determine the prognostic …

PURPOSE: To perform a prospective, intention-to-treat clinical trial to determine the long-
term survival rates of patients with hepatic cirrhosis and early-stage hepatocellular …

BACKGROUND/AIMS: To assess the effectiveness and the safety of radio-frequency thermal
ablation (RFTA) in patients with hepatocellular carcinoma (HCC)≤ 5cm in compensated …